Christian P. Stevenson, Ph.D.

Christian P. Stevenson, Ph.D. is a patent agent in the Patent Counseling and Prosecution practice of Dechert’s Intellectual Property group. Dr. Stevenson assists clients with patent application drafting and prosecution in the U.S. and internationally, freedom-to-operate analyses and intellectual property due diligence. He has experience across a broad range of technologies, including pharmaceuticals, medical devices, drug delivery technologies, chemical processes, biomaterials, agrochemicals and cosmetics.

In addition to his legal experience, Dr. Stevenson is also an accomplished research scientist, having conducted medicinal chemistry and pre-clinical drug discovery at Merck & Co., Inc.  He designed and synthesized novel compounds targeting ion channels, g-protein-coupled receptors and soluble enzymes as potential treatments for diabetes and pain. This work is the subject of numerous issued patents and patent applications.

Dr. Stevenson’s doctoral research focused on the total synthesis of peloruside A, as well as synthetic and mechanistic investigations of the hydrolytic kinetic resolution of terminal epoxides. His research on this subject has been published in peer-reviewed journals, including Journal of the American Chemical Society, Angewandte Chemie and Organic Syntheses.

Prior to joining Dechert, Dr. Stevenson was a scientific advisor at Goodwin Procter and a director of client services at open-innovation and crowdsourcing startup, InnoCentive.